figshare
Browse
ionc_a_1503420_sm5539.docx (22.55 kB)

KRAS mutation status, comorbidity, and mortality in patients with metastatic colorectal cancer in Denmark

Download (22.55 kB)
journal contribution
posted on 2018-09-28, 10:02 authored by Anne Gulbech Ording, Buket Öztürk, Karen-Lise Garm Spindler, Henrik Toft Sørensen, Margaret McCusker, Vera Ehrenstein
KRAS mutation status, comorbidity, and mortality in patients with metastatic colorectal cancer in Denmark

Funding

This work was supported by Roche Diagnostics (F. Hoffmann-La Roche Holding AG) under an institutional research grant; the Program for Clinical Research Infrastructure (PROCRIN), established by the Lundbeck Foundation and the Novo Nordisk Foundation; the Danish Cancer Society; and the Aarhus University Research Foundation.

History

Usage metrics

    Acta Oncologica

    Categories

    Keywords

    KRAS mutation statusmetastatic colorectal cancercomorbidityDenmark KRAS mutation statusmortality

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC